Alphamab Oncology gears up for HK IPO
Chinese biopharmaceutical company Alphamab Oncology is planning to start sounding out investors for its Hong Kong IPO later this week, according to a source close to the transaction.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: